Compugen Ltd.

NASDAQ: CGEN · Real-Time Price · USD
1.41
0.02 (1.44%)
At close: May 22, 2025, 12:00 PM

Compugen Statistics

Share Statistics

Compugen has 93.51M shares outstanding. The number of shares has increased by 4.45% in one year.

Shares Outstanding 93.51M
Shares Change (YoY) 4.45%
Shares Change (QoQ) 4.44%
Owned by Institutions (%) 13.65%
Shares Floating n/a
Failed to Deliver (FTD) Shares 15,282
FTD / Avg. Volume 5.63%

Short Selling Information

The latest short interest is 1.72M, so 1.84% of the outstanding shares have been sold short.

Short Interest 1.72M
Short % of Shares Out 1.84%
Short % of Float 1.9%
Short Ratio (days to cover) 9.99

Valuation Ratios

The PE ratio is -9.63 and the forward PE ratio is -14.15. Compugen's PEG ratio is 0.4.

PE Ratio -9.63
Forward PE -14.15
PS Ratio 4.92
Forward PS 3.3
PB Ratio 2.49
P/FCF Ratio 2.77
PEG Ratio 0.4
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Compugen.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.26, with a Debt / Equity ratio of 0.05.

Current Ratio 5.26
Quick Ratio 5.26
Debt / Equity 0.05
Debt / EBITDA -0.2
Debt / FCF 0.06
Interest Coverage -437.97

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $376,540.54
Profits Per Employee $-192,310.81
Employee Count 74
Asset Turnover 0.24
Inventory Turnover n/a

Taxes

Income Tax 4.52M
Effective Tax Rate -46.58%

Stock Price Statistics

The stock price has increased by -40.6% in the last 52 weeks. The beta is 2.62, so Compugen's price volatility has been higher than the market average.

Beta 2.62
52-Week Price Change -40.6%
50-Day Moving Average 1.43
200-Day Moving Average 1.73
Relative Strength Index (RSI) 49.48
Average Volume (20 Days) 271,593

Income Statement

In the last 12 months, Compugen had revenue of 27.86M and earned -14.23M in profits. Earnings per share was -0.16.

Revenue 27.86M
Gross Profit 19.93M
Operating Income -14.89M
Net Income -14.23M
EBITDA -14.4M
EBIT -14.89M
Earnings Per Share (EPS) -0.16
Full Income Statement

Balance Sheet

The company has 18.23M in cash and 2.91M in debt, giving a net cash position of 15.32M.

Cash & Cash Equivalents 18.23M
Total Debt 2.91M
Net Cash 15.32M
Retained Earnings -488.76M
Total Assets 115M
Working Capital 85.84M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 49.6M and capital expenditures -118K, giving a free cash flow of 49.49M.

Operating Cash Flow 49.6M
Capital Expenditures -118K
Free Cash Flow 49.49M
FCF Per Share 0.55
Full Cash Flow Statement

Margins

Gross margin is 71.54%, with operating and profit margins of -53.44% and -51.07%.

Gross Margin 71.54%
Operating Margin -53.44%
Pretax Margin -34.84%
Profit Margin -51.07%
EBITDA Margin -51.7%
EBIT Margin -53.44%
FCF Margin 177.6%

Dividends & Yields

CGEN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for CGEN is $4, which is 187.8% higher than the current price. The consensus rating is "Buy".

Price Target $4
Price Target Difference 187.8%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Scores

Altman Z-Score -3.96
Piotroski F-Score 1